Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inozyme Pharma, Inc. - Common Stock (NQ:INZY)

4.000 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 30, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	4.000
Bid (Size)	3.990 (689)
Ask (Size)	4.010 (44)
Prev. Close	4.000
Today's Range	4.000 - 4.000
52wk Range	0.7210 - 4.000
Shares Outstanding	61,729,666
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

June 20, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

May 27, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+196.3%	+196.3%

More News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

May 27, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZY

May 21, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

May 19, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWTX, NVEE, CHTR, INZY on Behalf of Shareholders

May 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Gold Down Over 1%; Flowers Foods Posts Weak Earnings ↗

May 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 16, 2025

Via Benzinga

Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens ↗

May 16, 2025

Via Stocktwits

Synergy CHC Corp. (NASDAQ: SNYR) Reports Strong Q1, Signals 2025 Expansion in GLP-1 and Global Markets – More Stocks Inside

May 16, 2025

Via AB Newswire

US Stocks Edge Higher; Consumer Sentiment Falls In May ↗

May 16, 2025

Via Benzinga

INZY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inozyme Pharma, Inc. Is Fair to Shareholders

May 16, 2025

From Halper Sadeh LLC

Via Business Wire

BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover ↗

May 16, 2025

Via Investor's Business Daily

Shareholder Alert: The Ademi Firm investigates whether Inozyme Pharma, Inc. is obtaining a Fair Price for its Public Shareholders

May 16, 2025

From Ademi & Fruchter LLP

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 16, 2025

Via Benzinga

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 14, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

April 10, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference

March 31, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights

March 10, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference

February 24, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025

February 21, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates

January 10, 2025

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 27, 2024

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma to Present at Upcoming Investor Conferences

November 11, 2024

From Inozyme Pharma Inc.

Via GlobeNewswire

Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights

November 05, 2024

From Inozyme Pharma Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Inozyme Pharma, Inc. - Common Stock publicly traded?

Yes, Inozyme Pharma, Inc. - Common Stock is publicly traded.

What exchange does Inozyme Pharma, Inc. - Common Stock trade on?

Inozyme Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inozyme Pharma, Inc. - Common Stock?

The ticker symbol for Inozyme Pharma, Inc. - Common Stock is INZY on the Nasdaq Stock Market

What is the current price of Inozyme Pharma, Inc. - Common Stock?

The current price of Inozyme Pharma, Inc. - Common Stock is 4.000

When was Inozyme Pharma, Inc. - Common Stock last traded?

The last trade of Inozyme Pharma, Inc. - Common Stock was at 06/30/25 04:00 PM ET

What is the market capitalization of Inozyme Pharma, Inc. - Common Stock?

The market capitalization of Inozyme Pharma, Inc. - Common Stock is 246.92M

How many shares of Inozyme Pharma, Inc. - Common Stock are outstanding?

Inozyme Pharma, Inc. - Common Stock has 247M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.